Clorox (CLX) Stock Forecast, Price & News

13 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Clorox in the last year. There are currently 7 sell ratings, 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" CLX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLX, but not buy additional shares or sell existing shares.
View CLX analyst ratings or view top-rated stocks.

13 Wall Street research analysts have issued 12-month price targets for Clorox's shares. Their CLX share price forecasts range from $124.00 to $185.00. On average, they anticipate the company's share price to reach $148.54 in the next twelve months. This suggests that the stock has a possible downside of 5.4%.
View analysts price targets for CLX or view top-rated stocks among Wall Street analysts.

Clorox's stock was trading at $140.33 at the beginning of the year. Since then, CLX stock has increased by 11.8% and is now trading at $156.94.
View the best growth stocks for 2023 here.

Clorox saw a decrease in short interest during the month of May. As of May 15th, there was short interest totaling 4,310,000 shares, a decrease of 16.8% from the April 30th total of 5,180,000 shares. Based on an average daily volume of 1,190,000 shares, the short-interest ratio is presently 3.6 days. Approximately 3.5% of the shares of the company are sold short.
View Clorox's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 2nd 2023.
View our CLX earnings forecast.

The Clorox Company (NYSE:CLX) announced its quarterly earnings data on Tuesday, May, 2nd. The company reported $1.51 EPS for the quarter, beating analysts' consensus estimates of $1.22 by $0.29. The firm had revenue of $1.92 billion for the quarter, compared to the consensus estimate of $1.82 billion. Clorox had a trailing twelve-month return on equity of 114.67% and a net margin of 1.03%. The company's quarterly revenue was up 5.9% on a year-over-year basis. During the same quarter last year, the firm earned $1.31 EPS.
Read the conference call transcript.

Clorox declared a quarterly dividend on Tuesday, February 14th. Shareholders of record on Wednesday, April 26th will be given a dividend of $1.18 per share on Friday, May 12th. This represents a $4.72 dividend on an annualized basis and a dividend yield of 3.01%. The ex-dividend date is Tuesday, April 25th.
Read our dividend analysis for CLX.

ETFs with the largest weight of Clorox (NYSE:CLX) stock in their portfolio include Natixis Vaughan Nelson Select ETF (VNSE), Invesco S&P 500 Equal Weight Consumer Staples ETF (RHS), VanEck Morningstar ESG Moat ETF (MOTE), Invesco S&P 500 High Dividend Low Volatility ETF (SPHD), Victoryshares Dividend Accelerator ETF (VSDA), Nuveen ESG Mid-Cap Value ETF (NUMV), FT Cboe Vest S&P 500 Dividend Aristocrats Target Income ETF (KNG) and Federated Hermes U.S. Strategic Dividend ETF (FDV).

Clorox (NYSE:CLX) pays an annual dividend of $4.72 per share and currently has a dividend yield of 2.97%. The company has been increasing its dividend for 36 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 813.81%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, CLX will have a dividend payout ratio of 84.29% in the coming year. This indicates that the company may not be able to sustain their current dividend.
Read our dividend analysis for CLX.

Clorox updated its FY 2023 earnings guidance on Wednesday, May, 3rd. The company provided earnings per share guidance of $4.35-$4.50 for the period, compared to the consensus earnings per share estimate of $4.30. The company issued revenue guidance of $7.18 billion-$7.25 billion, compared to the consensus revenue estimate of $7.12 billion.

17 employees have rated Clorox Chief Executive Officer Linda Rendle on Glassdoor.com. Linda Rendle has an approval rating of 94% among the company's employees. This puts Linda Rendle in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Clorox investors own include Johnson & Johnson (JNJ), AbbVie (ABBV), NVIDIA (NVDA), Verizon Communications (VZ), AT&T (T), Walt Disney (DIS), Home Depot (HD), Procter & Gamble (PG), Intel (INTC) and JPMorgan Chase & Co. (JPM).

Clorox trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLX."

Clorox's stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (7.65%), State Street Corp (7.08%), Geode Capital Management LLC (2.20%), Stifel Financial Corp (2.09%), FMR LLC (1.51%) and Federated Hermes Inc. (1.15%). Insiders that own company stock include A D David Mackay, Andrew J Mowery, Benno O Dorer, Denise Garner, Diego J Barral, Eric H Reynolds, Kevin B Jacobsen, Laura Stein and William S Bailey.
View institutional ownership trends.

Shares of CLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CLX stock can currently be purchased for approximately $156.94.

Clorox (NYSE:CLX) has a market capitalization of $19.40 billion and generates $7.11 billion in revenue each year. The company earns $462 million in net income (profit) each year or $0.58 on an earnings per share basis.

The company employs 9,000 workers across the globe.

Clorox's mailing address is 1221 BROADWAY, OAKLAND CA, 94612. The official website for the company is www.thecloroxcompany.com. The company can be reached via phone at (510) 271-7000, via email at investorrelations@clorox.com, or via fax at 510-832-1463.